Abstract
The diagnostic procedures in patients with suspected fatty liver disease—with or without known alcohol consumption—should be standardized and generally accepted. We therefore present a guideline, summarizing the current concepts of etiology, diagnostic as well as differential diagnostic of patients with fatty liver disease. Alcoholic as well as and non-alcoholic fatty liver are characterised by lipid deposition in hepatocytes. The diagnosis of steatosis is made when lipid deposition exceeds 5% of hepatocytes, while involvement of more than 50% is called “fatty liver”. An additional inflammatory reaction leads to alcoholic (ASH) or non-alcoholic steatohepatitis (NASH). Steatohepatitis is present when both inflammatory infiltrates of mixed cells in the small liver lobules as well as liver cell injury in terms of ballooning can be detected. Liver biopsy represents the “golden standard” for confirming diagnosis and determining inflammatory activity and potential fibrosis of fatty liver disease. The differential diagnosis of ASH vs. NASH cannot be made on the basis of histological criteria alone. Steatosis, inflammatory changes and hepatocytic injury can be semiquantified as a “Brunt Score” or “NAS” (NAFLD activity score), providing the basis on which to decide whether or not steatohepatitis is present. People at increased risk of developing a fatty liver possess an increased risk of developing chemotherapy-associated steatohepatitis. Histologically, pediatric NASH differs from adult NASH and is often only clinically manifest through a mild if persistent elevation in transaminases.
References
Ludwig J, Viggiano TR, McGill DB et al (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438
Bacon BR, Farahvash MJ, Janney CG et al (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103–1109
Ludwig J, McGill DB, Lindor KD (1997) Review: nonalcoholic steatohepatitis. J Gastroenterol Hepatol 12:398–403
Burt AD, Mutton A, Day CP (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15:246–258
Church TS, Kuk JL, Ross R et al (2006) Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 130:2023–2030
Dancygier H (2006) Pathogenese und Therapie der nichtalkoholischen Fettlebererkrankungen. Dtsch Ärzteblatt 103:A1301–A1307
Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112
Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:3–16
Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37:1202–1219
Cortez-Pinto H, de Moura MC, Day CP (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44:197–208
Day CP (2006) Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med 6:19–25
Bellentani S, Bedogni G, Miglioli L et al (2004) The epidemiology of fatty liver. Eur J Gastroenterol Hepatol 16:1087–1093
Alfire ME, Treem WR (2006) Nonalcoholic fatty liver disease. Pediatr Ann 35:290–299
Kacerovsky M, Roden M (2007) Nichtalkoholische Fettleber. Diabetologe 3:176–183
Mendez-Sanchez N, Arrese M, Zamora-Valdes D et al (2007) Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 27:423–433
Caldwell SH, Oelsner DH, Iezzoni JC et al (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29:664–669
Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845
Day CP (2002) Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16:663–678
Chitturi S, Abeygunasekera S, Farrell GC et al (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373–379
Duvnjak M, Lerotic I, Barsic N et al (2007) Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 13:4539–4550
Edmison J, McCullough AJ (2007) Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 11:75–104
Medina J, Fernandez-Salazar LI, Garcia-Buey L et al (2004) Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27:2057–2066
Targher G, Bertolini L, Rodella S et al (2006) Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 64:679–683
Dufour JF, Oneta CM (2004) Alcoholic and non-alcoholic steatohepatitis. Ther Umsch 61:505–512
AGA (2002) American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 123:1702–1704
Gramlich T, Kleiner DE, McCullough AJ et al (2004) Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol 35:196–199
Sonsuz A, Basaranoglu M, Ozbay G (2000) Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95:1370–1371
Wieckowska A, Zein NN, Yerian LM et al (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44:27–33
Angulo P, Hui JM, Marchesini G et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45:846–854
Kleiner DE, Brunt EM, Van NM et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321
Brunt EM, Tiniakos DG (2005) Pathological features of NASH. Front Biosci 10:1475–1484
Brunt EM, Tiniakos DG (2002) Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 16:691–707
Brunt EM (2002) Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 6:399–420
Brunt EM, Ramrakhiani S, Cordes BG et al (2003) Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod Pathol 16:49–56
Brunt EM, Neuschwander-Tetri BA, Oliver D et al (2004) Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 35:1070–1082
Brunt EM (2005) Pathology of nonalcoholic steatohepatitis. Hepatol Res 33:68–71
Brunt EM (2005) Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn Pathol 22:330–338
Falck-Ytter Y, Younossi ZM, Marchesini G et al (2001) Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 21:17–26
Matteoni CA, Younossi ZM, Gramlich T et al (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419
Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906
Teli MR, James OF, Burt AD et al (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714–1719
Mofrad P, Contos MJ, Haque M et al (2003) Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37:1286–1292
Angulo P, Lindor KD (2002) Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17(Suppl):S186–S190
Neuschwander-Tetri BA (2002) Evolving pathophysiologic concepts in nonalcoholic steatohepatitis. Curr Gastroenterol Rep 4:31–36
Joy D, Thava VR, Scott BB (2003) Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 15:539–543
Adams LA, Talwalkar JA (2006) Diagnostic evaluation of nonalcoholic fatty liver disease. J Clin Gastroenterol 40:S34–S38
Wieckowska A, McCullough AJ, Feldstein AE (2007) Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46:582–589
Harrison SA, Torgerson S, Hayashi PH (2003) The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98:2042–2047
Younossi ZM, Jarrar M, Nugent C et al (2008) A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 18(11):1430–1437
Castera L, Forns X, Alberti A (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48:835–847
Friedrich-Rust M, Ong MF, Martens S et al (2008) Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 134:960–974
Bonekamp S, Kamel I, Solga S et al (2009) Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 50:17–35
Strassburg CP, Manns MP (2006) Approaches to liver biopsy techniques—revisited. Semin Liver Dis 26:318–327
Tannapfel A, Reinacher-Schick A (2008) Chemotherapy associated hepatotoxicity in the treatment of advanced colorectal cancer (CRC). Z Gastroenterol 46:435–440
Nocito A, El-Badry AM, Clavien PA (2006) When is steatosis too much for transplantation? J Hepatol 45:494–499
Rousselet MC, Michalak S, Dupre F et al (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41:257–264
Lackner C, Gogg-Kamerer M, Zatloukal K et al (2008) Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 48:821–828
Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474
Brunt EM (2007) Pathology of fatty liver disease. Mod Pathol 20(Suppl 1):S40–S48
Schwimmer JB, Behling C, Newbury R et al (2005) Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42:641–649
Mendler MH, Kanel G, Govindarajan S (2005) Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. Liver Int 25:294–304
Oneta CM, Dufour JF (2003) Diagnostik, Prognose und therapeutische Möglichkeiten der nicht-alkoholischen Fettlebererkrankung. Schweiz Med Forum 37:862–868
Reid AE (2001) Nonalcoholic steatohepatitis. Gastroenterology 121:710–723
Sanyal AJ, Banas C, Sargeant C et al (2006) Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43:682–689
DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22:27–42
Karoui M, Penna C, min-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7
Tannapfel A, Geissler F, Witzigmann H et al (2001) Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen. Transplant Proc 33:3283–3284
Gentilucci UV, Santini D, Vincenzi B et al (2006) Chemotherapy-induced steatohepatitis in colorectal cancer patients. J Clin Oncol 24:5467–5468
Zivkovic AM, German JB, Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86:285–300
Aloia T, Sebagh M, Plasse M et al (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983–4990
Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072
Nordlinger B, Van CE, Rougier P et al (2007) Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 43:2037–2045
Nakano H, Oussoultzoglou E, Rosso E et al (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118–124
Baumann U (2005) Die kindliche Fettlebererkrankung. Dtsch Ärzteblatt 102:A2634–A2639
Rashid M, Roberts EA (2000) Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30:48–53
Roberts EA (2002) Steatohepatitis in children. Best Pract Res Clin Gastroenterol 16:749–765
Hubscher SG (2004) Role of liver biopsy in the assessment of non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol 16:1107–1115
Moss A, Wabitsch M, Kromeyer-Hauschild K et al (2007) Prevalence of overweight and adiposity in German school children. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:1424–1431
Roberts EA (2007) Non-alcoholic steatohepatitis in children. Clin Liver Dis 11:155–172
Papandreou D, Rousso I, Mavromichalis I (2007) Update on non-alcoholic fatty liver disease in children. Clin Nutr 26:409–415
Schwimmer JB (2007) Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Semin Liver Dis 27:312–318
Williams CD, Stengel J, Asike MI et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131
Valenti L, Alisi A, Galmozzi E et al (2010) I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52:1274–1280
Petersen KF, Dufour S, Hariri A et al (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362:1082–1089
Chalasani N, Guo X, Loomba R et al (2010) Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 139:1567–1576
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tannapfel, A., Denk, H., Dienes, HP. et al. Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 458, 511–523 (2011). https://doi.org/10.1007/s00428-011-1066-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-011-1066-1